Insights

The Brave Brand

Strategic intelligence for leaders shaping what’s next.

Latest

Will Alaynick on the Geometry of Life Science Tools

Alaynick brings a scientist-turned-investor lens to early-stage biotech, unpacking the geometry of tools, capital, and ecosystem timing that determines what gets built and what scales.

What Biotech Founders Struggle to Articulate

Biotech Infrastructure Is Not Neutral

Jeremy Houser on Biotech as Public Infrastructure

Archive

Understanding Biotech in the Present Tense

Understanding biotech today requires clarity about its environment, its pressures, and its possibilities. Only then can we ask what comes next.

A 2025 Biotech Reflection

A reflection on the state of innovation, the role of trust, and the evolving expectations on science and story.

What the Best Biotech Brands Get Right

Breakthrough science is essential. So is the trust that surrounds it. This piece outlines a foundational view of how story and credibility shape the future of biotech.

Trust, Story, and the Future of Biotech

Brand success in biotech now depends on trust and narrative. Science earns attention, but story builds confidence, engages stakeholders, and fuels growth.

Why Brand Is Becoming a Biotech Growth Driver

The era of “science speaks for itself” is over. In modern biotech, brand drives trust. Trust drives capital, partnerships, and growth.

Frameworks & Tools

You Have One Shot at JPM. Is Your Story Ready?

JP Morgan Healthcare Conference is nine weeks away. Take a deep breath. I’m here to help.